Back to Directory
Last Updated: 03/06/2026
EnsiliTech
Bristol
Founded 2021
Silica encapsulation platform eliminating cold chain for biologics
EnsiliTech is a biotechnology company developing ensilication, a patented platform technology that encases vaccines, antibodies, and other biologics within a silica matrix to render them thermally stable without refrigeration.
The technology is applicable to existing and new biopharmaceutical formulations, enabling storage and transport at temperatures up to 50°C.
EnsiliTech is developing applications across vaccines and monoclonal antibody therapeutics, with partners including the Centre for Process Innovation.
Company Notes
Previously Known As
Ensilicated Technologies